THE Pharmaceutical Benefits Advisory Committee (PBAC) as published its latest list of funding recommendations including positive, rejected and deferred decisions for the PBS funding of drugs.
Drug Utilisation Sub-Committee (DUSC) findings were also considered - visit pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Jan 17
